AI & ChatGPT searches , social queriess for EVINACUMAB

Search references for EVINACUMAB. Phrases containing EVINACUMAB

See searches and references containing EVINACUMAB!

AI searches containing EVINACUMAB

EVINACUMAB

  • Evinacumab

    • Monoclonal antibody

    Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH)

    Evinacumab

    Evinacumab

  • Ultragenyx

    • American biopharmaceutical company

    trials. The company also holds the non-US commercial rights to Regeneron’s evinacumab-dgnb, which is approved by the FDA and EMA. The company also has therapies

    Ultragenyx

    Ultragenyx

    Ultragenyx

  • Monoclonal antibody

    • Antibodies from clones of the same blood cell

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Monoclonal antibody

    Monoclonal antibody

    Monoclonal_antibody

  • Amitriptyline

    • Tricyclic antidepressant

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Amitriptyline

    Amitriptyline

    Amitriptyline

  • Aducanumab

    • Monoclonal antibody against amyloid beta

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Aducanumab

    Aducanumab

  • Alirocumab

    • Pharmaceutical drug

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Alirocumab

    Alirocumab

  • Antineoplastic

    • Class of drugs used to treat malignant tumors

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Antineoplastic

    Antineoplastic

    Antineoplastic

  • Lecanemab

    • Monoclonal antibody against amyloid beta

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Lecanemab

    Lecanemab

  • Donanemab

    • Monoclonal antibody against amyloid beta

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Donanemab

    Donanemab

  • Evolocumab

    • Pharmaceutical drug

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Evolocumab

    Evolocumab

  • Bimagrumab

    • Chemical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Bimagrumab

    Bimagrumab

  • Erenumab

    • Chemical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Erenumab

    Erenumab

    Erenumab

  • Emicizumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Emicizumab

    Emicizumab

    Emicizumab

  • Dexamethasone

    • Corticosteroid medication

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Dexamethasone

    Dexamethasone

    Dexamethasone

  • Anti-amyloid antibodies

    • Drug class

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Anti-amyloid antibodies

    Anti-amyloid_antibodies

  • Humanized antibody

    • Antibodies from non-human species made nearly identical with human ones

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Humanized antibody

    Humanized_antibody

  • Enoticumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Enoticumab

    Enoticumab

  • Insulin

    • Peptide hormone

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Insulin

    Insulin

    Insulin

  • Prasinezumab

    • Experimental monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Prasinezumab

    Prasinezumab

  • Ralpancizumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Ralpancizumab

    Ralpancizumab

  • Testosterone

    • Primary male sex hormone

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Testosterone

    Testosterone

    Testosterone

  • Fibroblast growth factor receptor-like 1

    • Protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Fibroblast growth factor receptor-like 1

    Fibroblast growth factor receptor-like 1

    Fibroblast_growth_factor_receptor-like_1

  • Romosozumab

    • Pharmaceutical drug

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Romosozumab

    Romosozumab

  • Vanucizumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Vanucizumab

    Vanucizumab

  • Fremanezumab

    • Pharmaceutical biological monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Fremanezumab

    Fremanezumab

  • Dihexa

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Dihexa

    Dihexa

    Dihexa

  • Vascular endothelial growth factor

    • Protein involved in blood vessel growth

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Vascular endothelial growth factor

    Vascular_endothelial_growth_factor

  • Concizumab

    • Medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Concizumab

    Concizumab

  • Binimetinib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Binimetinib

    Binimetinib

    Binimetinib

  • Marstacimab

    • Medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Marstacimab

    Marstacimab

  • Galcanezumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Galcanezumab

    Galcanezumab

    Galcanezumab

  • Platelet-derived growth factor receptor

    • Cell surface receptors

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Platelet-derived growth factor receptor

    Platelet-derived growth factor receptor

    Platelet-derived_growth_factor_receptor

  • Transforming growth factor

    • Biomarker indicative of breast cancer patients' prognosis

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Transforming growth factor

    Transforming_growth_factor

  • KIT (gene)

    • Mammalian protein and protein-coding gene

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    KIT (gene)

    KIT (gene)

    KIT_(gene)

  • Erythropoietin

    • Protein that stimulates red blood cell production

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Erythropoietin

    Erythropoietin

    Erythropoietin

  • Denosumab

    • Human monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Denosumab

    Denosumab

  • Brigatinib

    • ALK inhibitor for treatment of non-small-cell lung cancer

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Brigatinib

    Brigatinib

    Brigatinib

  • Insulin-like growth factor 1

    • Protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Insulin-like growth factor 1

    Insulin-like growth factor 1

    Insulin-like_growth_factor_1

  • Familial hypercholesterolemia

    • Genetic disorder characterized by high cholesterol levels

    hypercholesterolemia. Gene therapy is a possible future alternative. Evinacumab, a monoclonal antibody inhibiting angiopoietin-like protein 3, was approved

    Familial hypercholesterolemia

    Familial hypercholesterolemia

    Familial_hypercholesterolemia

  • ATC code C10

    • Pharmaceutical drug classification

    C10AX14 Alirocumab C10AX15 Bempedoic acid C10AX16 Inclisiran C10AX17 Evinacumab C10AX18 Volanesorsen C10AX19 Lerodalcibep C10BA01 Lovastatin and nicotinic

    ATC code C10

    ATC_code_C10

  • Dehydroepiandrosterone

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Dehydroepiandrosterone

    Dehydroepiandrosterone

    Dehydroepiandrosterone

  • Imatinib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Imatinib

    Imatinib

    Imatinib

  • Neurotrophin

    • Family of proteins

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Neurotrophin

    Neurotrophin

    Neurotrophin

  • Fibroblast growth factor

    • Family of proteins involved in anatomical development

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Fibroblast growth factor

    Fibroblast_growth_factor

  • Idarucizumab

    • Medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Idarucizumab

    Idarucizumab

  • Brain-derived neurotrophic factor

    • Protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Brain-derived neurotrophic factor

    Brain-derived neurotrophic factor

    Brain-derived_neurotrophic_factor

  • List of therapeutic monoclonal antibodies

    • TIGIT Etrolizumab mab humanized integrin β7 inflammatory bowel disease Evinacumab Evkeeza mab human angiopoietin 3 Y dyslipidemia Evolocumab Repatha mab

    List of therapeutic monoclonal antibodies

    List of therapeutic monoclonal antibodies

    List_of_therapeutic_monoclonal_antibodies

  • Trevogrumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Trevogrumab

    Trevogrumab

  • ACD856

    • TrkA and TrkB positive modulator

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    ACD856

    ACD856

  • Bedinvetmab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Bedinvetmab

    Bedinvetmab

    Bedinvetmab

  • Caplacizumab

    • Chemical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Caplacizumab

    Caplacizumab

  • Fibroblast growth factor 21

    • Protein-coding gene in mammals

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Fibroblast growth factor 21

    Fibroblast growth factor 21

    Fibroblast_growth_factor_21

  • Repotrectinib

    • Medication

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Repotrectinib

    Repotrectinib

    Repotrectinib

  • Abelacimab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Abelacimab

    Abelacimab

  • Anti-VEGF

    • Medication which blocks growth of blood vessels

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Anti-VEGF

    Anti-VEGF

    Anti-VEGF

  • IGF-1 LR3

    • Synthetic protein

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    IGF-1 LR3

    IGF-1_LR3

  • Testosterone (medication)

    • Medication and naturally occurring steroid hormone

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Testosterone (medication)

    Testosterone (medication)

    Testosterone_(medication)

  • Growth factor

    • Protein or other substance that stimulates cellular proliferation

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Growth factor

    Growth_factor

  • Cerebrolysin

    • Experimental drug for neurodegenerative disorders

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Cerebrolysin

    Cerebrolysin

  • Receptor tyrosine kinase

    • Class of enzymes

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Receptor tyrosine kinase

    Receptor tyrosine kinase

    Receptor_tyrosine_kinase

  • Wnt signaling pathway

    • Group of signal transduction pathways involved in embryonic development

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Wnt signaling pathway

    Wnt_signaling_pathway

  • Lenvatinib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Lenvatinib

    Lenvatinib

    Lenvatinib

  • Eptinezumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Eptinezumab

    Eptinezumab

  • Tropoflavin

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Tropoflavin

    Tropoflavin

    Tropoflavin

  • HER2

    • Mammalian protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    HER2

    HER2

    HER2

  • Solanezumab

    • Monoclonal antibody medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Solanezumab

    Solanezumab

  • Filgrastim

    • Medication

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Filgrastim

    Filgrastim

    Filgrastim

  • Anti-α-synuclein drug

    • Drugs that inhibit α-synuclein

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Anti-α-synuclein drug

    Anti-α-synuclein_drug

  • Figitumumab

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Figitumumab

    Figitumumab

  • Tyrosine kinase inhibitor

    • Drug typically used in cancer treatment

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Tyrosine kinase inhibitor

    Tyrosine kinase inhibitor

    Tyrosine_kinase_inhibitor

  • Bevacizumab

    • Medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Bevacizumab

    Bevacizumab

  • Gantenerumab

    • Monoclonal antibody protein

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Gantenerumab

    Gantenerumab

    Gantenerumab

  • Burosumab

    • Monoclonal antibody designed to treat X-linked hypophosphatemia

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Burosumab

    Burosumab

  • R13 (drug)

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    R13 (drug)

    R13 (drug)

    R13_(drug)

  • Abciximab

    • Pharmaceutical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Abciximab

    Abciximab

    Abciximab

  • Osimertinib

    • Chemical compound, used as a medication to treat lung cancer

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Osimertinib

    Osimertinib

    Osimertinib

  • EPHA7

    • Protein-coding gene in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    EPHA7

    EPHA7

    EPHA7

  • Prasterone enanthate

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Prasterone enanthate

    Prasterone enanthate

    Prasterone_enanthate

  • Vemurafenib

    • Targeted cancer drug

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Vemurafenib

    Vemurafenib

    Vemurafenib

  • Heparin-binding EGF-like growth factor

    • Protein-coding gene in the species Homo sapiens

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Heparin-binding EGF-like growth factor

    Heparin-binding EGF-like growth factor

    Heparin-binding_EGF-like_growth_factor

  • Nerve growth factor

    • Mammalian protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Nerve growth factor

    Nerve growth factor

    Nerve_growth_factor

  • Bapineuzumab

    • Chemical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Bapineuzumab

    Bapineuzumab

  • Trastuzumab deruxtecan

    • Medication

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Trastuzumab deruxtecan

    Trastuzumab deruxtecan

    Trastuzumab_deruxtecan

  • Vascular endothelial growth factor B

    • Protein-coding gene in the species Homo sapiens

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Vascular endothelial growth factor B

    Vascular endothelial growth factor B

    Vascular_endothelial_growth_factor_B

  • MST1

    • Protein-coding gene in the species Homo sapiens

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    MST1

    MST1

    MST1

  • Epidermal growth factor receptor

    • Transmembrane protein

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Epidermal growth factor receptor

    Epidermal growth factor receptor

    Epidermal_growth_factor_receptor

  • Erlotinib

    • Medication for treatment of non-small-cell lung cancer

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Erlotinib

    Erlotinib

    Erlotinib

  • Trastuzumab

    • Medication

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Trastuzumab

    Trastuzumab

    Trastuzumab

  • Cetuximab

    • Pharmaceutical drug

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Cetuximab

    Cetuximab

    Cetuximab

  • Dehydroepiandrosterone sulfate

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone_sulfate

  • List of drugs granted breakthrough therapy designation

    • adults, as monotherapy or in conjunction with an oral antidepressant Evinacumab As an adjunct to diet and exercise and other low-density lipoprotein-cholesterol

    List of drugs granted breakthrough therapy designation

    List_of_drugs_granted_breakthrough_therapy_designation

  • Integrin

    • Transmembrane receptors involved in cellular adhesion and signalling

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Integrin

    Integrin

    Integrin

  • Erythropoietin receptor

    • Protein-coding gene in the species Homo sapiens

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Erythropoietin receptor

    Erythropoietin receptor

    Erythropoietin_receptor

  • Pazopanib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Pazopanib

    Pazopanib

  • Prasterone

    • Medical usage of the prasterone compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Prasterone

    Prasterone

    Prasterone

  • Bosutinib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Bosutinib

    Bosutinib

    Bosutinib

  • Dasatinib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Dasatinib

    Dasatinib

    Dasatinib

  • Robert Hegele

    • drugs, including rosuvastatin, sitagliptin, evolocumab, inclisiran, and evinacumab. Several of these treatments became standard therapies following successful

    Robert Hegele

    Robert_Hegele

  • Vascular endothelial growth factor A

    • Protein involved in blood vessel growth

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Vascular endothelial growth factor A

    Vascular endothelial growth factor A

    Vascular_endothelial_growth_factor_A

  • Rociletinib

    • Cancelled developmental cancer drug

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Rociletinib

    Rociletinib

    Rociletinib

AI & ChatGPT searchs for online references containing EVINACUMAB

EVINACUMAB

AI search references containing EVINACUMAB

EVINACUMAB

AI search queriess for Facebook and twitter posts, hashtags with EVINACUMAB

EVINACUMAB

Follow users with usernames @EVINACUMAB or posting hashtags containing #EVINACUMAB

EVINACUMAB

Online names & meanings

  • Shrenik | ஷ்ரேநிக 

    • Boy/Male

    Tamil

    Shrenik | ஷ்ரேநிக 

    Organized

  • Vaishu

    • Girl/Female

    Hindu, Indian

    Vaishu

    Goddess Laxmi; Nickname of Vaishnavi

  • Nireshika

    • Girl/Female

    Hindu, Indian

    Nireshika

    Power of God; Love of Father

  • FESTUS

    • Male

    English

    FESTUS

    Roman Latin name derived from the word festus, FESTUS means "festival." In the bible, this is the name of the successor of Felix, the procurator of Judea who refused to bow to the pressure of the Jews who wanted him to condemn St. Paul to death for preaching. He is also known by the name Porcius.

  • Prabhchet

    • Boy/Male

    Indian, Punjabi, Sikh

    Prabhchet

    Absorbed in God

  • Kendle

    • Surname or Lastname

    English

    Kendle

    English : variant spelling of Kendall.South German : possibly from Kindel or Kindl (from a diminutive of Middle High German kint ‘child’), a nickname for a childish or childlike person.Possibly an altered spelling of German Kendler, variant of Kandler.

  • MEIFENG

    • Female

    Chinese

    MEIFENG

    beautiful wind.

  • Jeriel

    • Boy/Male

    American, Australian, Biblical, British, English, Hebrew, Netherlands

    Jeriel

    Strong; Open Minded; Fear; Vision of God

  • KÁROLY

    • Male

    Hungarian

    KÁROLY

    Hungarian form of German Karl, KÁROLY means "man."

  • HUW

    • Male

    Welsh

    HUW

    Welsh form of French Hugues, HUW means "heart," "mind," or "spirit."

AI search & ChatGPT queriess for Facebook and twitter users, user names, hashtags with EVINACUMAB

EVINACUMAB

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing EVINACUMAB

EVINACUMAB

AI searchs for Acronyms & meanings containing EVINACUMAB

EVINACUMAB

AI searches, Indeed job searches and job offers containing EVINACUMAB

Other words and meanings similar to

EVINACUMAB

AI search in online dictionary sources & meanings containing EVINACUMAB

EVINACUMAB